Achieve Life Sciences (ACHV) Tops Q3 EPS by 40c; Reports Cash and Cash Equivalents of $33.4M

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.71), $0.40 better than the analyst estimate of ($1.11).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Vivos Therapeutics posts 35% revenue gain but widens net loss
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c